Jenburkt Pharmaceuticals (JENBURPH) Share Price rises 13.1% to Rs 1,009

Jenburkt Pharmaceuticals Share Price is in focus after the stock traded at Rs 1,009, up 13.1% from the previous close of Rs 892.10, with market capitalisation at Rs 393.71 Cr. The latest Univest figures show a clear same-day price rise, and the move places Jenburkt Pharmaceuticals Share Price among the stronger names in the current market update. Univest figures confirm the price action, but they do not point to a specific company trigger. As of 08 October 2026 at 10:22:43 AM IST, the stock had already moved between Rs 880.10 and Rs 1,045, which makes the day’s range useful context for readers tracking Jenburkt Pharmaceuticals Share Price today. Investors watching Jenburkt Pharmaceuticals Share Price can next monitor whether the move is sustained around the current band while reviewing fundamentals and sector valuation. In Univest coverage, the stock’s share price rise is therefore being read mainly through verified price action and relative financial context.

Jenburkt Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,009
Previous Close	Rs 892.1
Today's Move	Rs 116.9 (+13.1%)
Open	Rs 888.8
High	Rs 1,045
Low	Rs 880.1
Market Capitalisation	Rs 393.71 crore
Market Cap Category	Micro Cap

Jenburkt Pharmaceuticals Ltd. (JENBURPH) rose to Rs 1,009 from the previous close of Rs 892.1, a move of Rs 116.9 or 13.1%. The stock opened at Rs 888.8, reached a high of Rs 1,045, recorded a low of Rs 880.1.

Jenburkt Pharmaceuticals Share Price today shows a strong intraday price rise, with the stock last traded at Rs 1,009 after opening at Rs 888.80 and moving as high as Rs 1,045. The share price gain of Rs 116.90 over the previous close reflects a 13.1% rise, while the day’s low of Rs 880.10 helps define the trading band seen so far. For readers following Jenburkt Pharmaceuticals Share Price live, the movement is notable because the stock has stayed well above the opening level and has already tested the upper end of the range. The current market capitalisation of Rs 393.71 Cr gives the price action a clear size context. In Univest language, the stock is trading with a visible share price rise, but the price action alone does not establish why it is rising today. That makes the next step a deeper look at Jenburkt Pharmaceuticals Share Price from a fundamental analysis angle.

Jenburkt Pharmaceuticals Ltd. (JENBURPH) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 393.71 crore
P/E Ratio	11.99x
P/B Ratio	1.94x
ROE	18.84%
ROCE	25.34%
EPS	Rs 74.39
Book Value Per Share	Rs 459.8
Dividend Yield	2.32%

Jenburkt Pharmaceuticals Ltd. (JENBURPH) fundamental metrics show P/E 11.99x, P/B 1.94x, ROE 18.84%, ROCE 25.34%. Taken on their own, these numbers offer context rather than a trading signal.

Jenburkt Pharmaceuticals Ltd. has a market capitalisation of Rs 393.71 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 11.99x, P/B at 1.94x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.84% and ROCE of 25.34%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 74.39, book value per share of Rs 459.8, dividend yield of 2.32%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	11.99x
Benchmark Median P/E	31.87x
Benchmark Average P/E	48.48x
Benchmark P/E Range	3.58x to 708.87x
Company P/B Ratio	1.94x
Benchmark Median P/B	2.98x
Company ROE	18.84%
Benchmark Median ROE	11.61%
Company ROCE	25.34%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 393.71 crore
Benchmark Median Market Cap	Rs 854.81 crore

Jenburkt Pharmaceuticals Ltd. (JENBURPH) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a P/E ratio of 11.99x, which is below the benchmark median of 31.87x, a difference of -62.38%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a ROE of 18.84%, which is above the benchmark median of 11.61%, a difference of +62.27%. Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a ROCE of 25.34%, which is above the benchmark median of 13.46%, a difference of +88.26%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,32,120.23	35.37	4.95	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,53,389.76	86.95	14.4	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,81,739.76	82.14	19.96	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,710.44	25.51	4.27	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,10,980.13	101.55	19.69	18.31	18.2

Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a P/E ratio of 11.99x compared with the displayed peer median of 82.14x. The comparison is relative and should not be read as a recommendation. Its ROE of 18.84% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 25.34% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a market capitalisation of Rs 393.71 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Jenburkt Pharmaceuticals

• Jenburkt Pharmaceuticals Share Price is rising today with a 13.1% gain and a current price of Rs 1,009.
• Jenburkt Pharmaceuticals Share Price moved within a wide intraday range, from Rs 880.10 to Rs 1,045, which keeps price action in focus.
• Jenburkt Pharmaceuticals Fundamental Analysis shows P/E, P/B, ROE, ROCE, EPS, book value and dividend yield that investors can compare with the sector.
• Jenburkt Pharmaceuticals Share Price trades below the same-industry median on P/E and P/B, while ROE and ROCE stand above the benchmark median.
• Jenburkt Pharmaceuticals Share Price is also notable in peer comparison because its market capitalisation is far below the larger Healthcare and Pharmaceuticals & Drugs names listed by Univest.

About Jenburkt Pharmaceuticals

Jenburkt Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Jenburkt Pharmaceuticals Share Price reflects a company that investors typically study through product economics, valuation ratios and return metrics rather than only through daily price movement. Based on the latest Univest figures, the company has a market capitalisation of Rs 393.71 Cr, a P/E ratio of 11.99, a P/B ratio of 1.94, ROE of 18.84%, ROCE of 25.34%, EPS of Rs 74.39, book value of Rs 459.8 and dividend yield of 2.32%. For Jenburkt Pharmaceuticals Share Price readers, that mix suggests a business profile where accounting value, profitability and capital efficiency all matter to interpretation. In broader stock analysis, the company is part of a competitive Pharmaceuticals & Drugs universe where valuation and operating returns are often compared closely across listed peers.

Frequently Asked Questions

Why is Jenburkt Pharmaceuticals Share Price rising today?

Ans. Jenburkt Pharmaceuticals Share Price is rising today because the stock is up 13.1% to Rs 1,009. Univest figures confirm the price action, but they do not point to a specific company trigger.

What is Jenburkt Pharmaceuticals Share Price today?

Ans. Jenburkt Pharmaceuticals Share Price today is Rs 1,009. It is higher than the previous close of Rs 892.10 and has already moved between Rs 880.10 and Rs 1,045 in intraday trade.

What does Jenburkt Pharmaceuticals stock news show today?

Ans. Jenburkt Pharmaceuticals Stock News today centres on a 13.1% share price rise and a market capitalisation of Rs 393.71 Cr. Univest data confirms the move, while leaving the reason unconfirmed.

How does Jenburkt Pharmaceuticals Share Price compare with the sector?

Ans. Jenburkt Pharmaceuticals Share Price trades at a P/E of 11.99 and a P/B of 1.94, both below the same-industry median. ROE and ROCE are above the benchmark median, which adds context.

What are the key fundamentals for Jenburkt Pharmaceuticals Share Price?

Ans. Jenburkt Pharmaceuticals Share Price is supported by EPS of Rs 74.39, book value of Rs 459.8, dividend yield of 2.32%, ROE of 18.84% and ROCE of 25.34%, alongside a P/E of 11.99.

How does Jenburkt Pharmaceuticals compare with peers?

Ans. Jenburkt Pharmaceuticals Share Price sits on a much smaller market capitalisation than listed peers, but its P/E and P/B are lower than the peer group shown. ROE and ROCE remain competitive versus several peers.

What is Jenburkt Pharmaceuticals market capitalisation?

Ans. Jenburkt Pharmaceuticals Share Price is backed by a market capitalisation of Rs 393.71 Cr. That places it below the same-industry median market cap of Rs 854.81 Cr in the latest Univest figures.

What is the previous close for Jenburkt Pharmaceuticals Share Price?

Ans. The previous close for Jenburkt Pharmaceuticals Share Price was Rs 892.10. The stock then opened at Rs 888.80 and later moved to Rs 1,045 before trading at Rs 1,009.

Track Jenburkt Pharmaceuticals Share Price on Univest

Use Jenburkt Pharmaceuticals Ltd. (JENBURPH) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Jenburkt Pharmaceuticals Share Price on Univest for live updates, valuation ratios, 52-week levels and market insights. Jenburkt Pharmaceuticals Share Price today can be followed alongside company fundamentals, peer context and market cap data in one place. For investors monitoring Jenburkt Pharmaceuticals Stock News, Univest keeps the share price rise, fundamental analysis and benchmark comparison easy to review without adding speculation.